Rivaroxaban in Peripheral Artery Disease After Revascularization: Worst Events and Net Outcomes in VOYAGER PAD. - Hogan S; Szarek M; Debus ES; Nehler M; Anand SS; Patel MR; Pap AF; Deng H; Hodge S; Haskell LP; Muehlhofer E; Berkowitz SE; et al. (Journal of the American Heart Association, 2025)